Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It offers the Relicann, a proprietary hemp-based cannabidiol chewing gum for the health and wellness. Its novel cannabinoid delivery technology targets diseases and disorders such as pain, inflammation, and wound care. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Toronto, Canada.
Revive Therapeutics - Ключевые показатели
Рыночная капитализация (RUB)
|
5,72 Млрд
|
Акции в свободном обращении (%)
|
97,80
|
Объём выпуска
|
320,01
|
Денежный поток/акцию в национальной валюте
|
|
Балансовая стоимость/акцию в национальной валюте
|
|
Волатильность за 60 дней
|
171,98
|
P/B коэффициент
|
|
Revive Therapeutics - Основная информация
Тикер
|
|
ISIN
|
CA7615161030
|
Индексы
|
|
Revive Therapeutics - О компании